Table 1.
Comparison of Previous Unbiased Proteomic Studies of AH and Vitreous in AMD (The Full List of the Proteins Presented in Supplementary Table S3)
Study | Rinsky et al. (2021) | Kim et al. (2012) | Koss et al. (2016) | Siwy et al. (2014) |
---|---|---|---|---|
Source of Sample | Aqueous | Aqueous | Vitreous | Vitreous |
Mass spectrometry analysis | ||||
AMD patients | 10 | 3 | 72 | 73 |
Controls | 10 | 3 | 16 | 15 |
Total proteins identified | 674 | 154 | 101 | 97 |
Proteins upregulated in AMD | 239 | 52 | 4 (up or down) | 19 |
Proteins upregulated in control | 86 | 22 | ||
Overlap with Rinsky et al. | N/A | |||
Validation set and potential biomarkers * | ||||
AMD patients | 30** | 6 | 36 | 4 |
Controls | 20 | 5 | 8 | 4 |
Number of proteins tested | 9 | 7 | 4 | 5 |
AMD Proteins Overlaping | 6 discovered in this study | 10 new proteins compared to previous studies | 40 | 8 |
aAMD and nvAMD.